http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2529549-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69c91bbf0395db010b4806f50d808c4e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D461-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D461-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435
filingDate 1983-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af28794f9093cdb987a28d311572732c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29292b39b8d35096263cd7254f497805
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ec428fb602912056b43b5773543b8c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41e04ade255a6d664a98b2011345b48f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93a6b67d9f152895e51a1c34251a17e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40c8eb5e701e4b702e8c83a1be929cd3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6cb3729b65365bcb045a0eea5415c2ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31eefb5edb348b831492974d56ec88b1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47ce47223b27bfb76b237dc27cb6e14c
publicationDate 1984-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber FR-2529549-A1
titleOfInvention EBURNANE OXIME-ETHERS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
abstract THE PRESENT INVENTION CONCERNS NEW OPTICALLY ACTIVE OR RACEMIC EBURNANE OXIME-ETHERS OF FORMULA IA ANDOU IB (CF DRAWING IN BOPI) OUR REPRESENTS A C OR C ALCOHYL GROUP; R REPRESENTS A CAC ALCOHOL GROUP, AND THE CONFIGURATION OF L 'HYDROGEN IN POSITION 3 AND OF GROUP R IS A, A ANDOU B, B OR A, B AND OR B, A AND THEIR ADDITIONAL SALTS OF ACIDS, A PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
priorityDate 1982-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2036744-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2085630-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2206090-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12699
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70695
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID428836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416129933
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID103689
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474485
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452656230
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415809126
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22485300
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID999
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412215776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559499
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415747309
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71203
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9550
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410519910
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558649
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54688690
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579639
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523755
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6350
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65065
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1549559
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591854

Total number of triples: 55.